BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-34

  1. 1,051 Posts.
    lightbulb Created with Sketch. 214
    I will take this as a positive news because I think some large pharma or institutions will start building position from now to next 3-6 months knowing BOT will have a commercially viable product with certainty.
    Watch this space, not fussed at all.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.